Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study

• Main Authors: Tiew-Hwa K Teng, PhD (Author), Jasper Tromp, MD (Author), Wan Ting Tay, MAppStat (Author), Inder Anand, MD (Author), Wouter Ouwerkerk, PhD (Author), Vijay Chopra, MD (Author), Gurpreet S Wander, DM (Author), Jonathan JL Yap, MBBS (Author), Michael R MacDonald, MBChB (Author), Chang Fen Xu, MBBS (Author), Yvonne MF Chia, MBBS (Author), Wataru Shimizu, MD (Author), A Mark Richards, MD (Author), Adriaan Voors, MD (Author), Carolyn SP Lam, MBBS (Author)
• Format: Book
• Published: Elsevier, 2018-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs), β blockers, and mineralocorticoid receptor antagonists (MRAs) are of proven benefit and are recommended by guidelines for management of patients with heart failure and reduced ejection fra...